What is Vaxcyte, Inc.'s net income?

Vaxcyte, Inc. (PCVX) reported net income of -$320.62M in Q1 2026.

How has Vaxcyte, Inc.'s net income changed year-over-year?

Vaxcyte, Inc.'s net income decreased by 127.8% year-over-year, from -$140.72M to -$320.62M.

What is the long-term trend for Vaxcyte, Inc.'s net income?

Over 4 years (2021 to 2025), Vaxcyte, Inc.'s net income has grown at a 66.4% compound annual growth rate (CAGR), from -$100.08M to -$766.63M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Vaxcyte, Inc. PCVX Net Income

Net Income at other companies

PfizerPFE

$2.7B-9.3%

Merck & Co.MRK

-$4.24B-183%

ModernaMRNA

-$1.34B-38.3%

Krystal Biotech, Inc.KRYS

$55.93M+56.5%

ImmunityBio, Inc.IBRX

-$632.8M-388%

Vertex PharmaceuticalsVRTX

$1.03B+59.6%

Segments

By segment

See full

Reportable Segment-$320.62M-128%

Other financials

Income statement

See full

Operating income-$345.9M-91.3%

Net income-$320.6M-128%

EPS (diluted)-$2.30-121%

Balance sheet

See full

Cash & equivalents$262.3M-24.7%

Total debt$116.3M+33.5%

Total equity$3.0B-6.4%

Total assets$3.3B-0.9%

Cash flow

See full

Operating cash flow-$280.6M-68.8%

CapEx$2.1M-61.2%

Free cash flow-$282.7M-64.7%

Valuation

See full

Market cap$7.43B+72.0%

Enterprise value$7.28B+78.6%

Returns & leverage

See full

Return on equity-30.6%+37.9pp

Debt / equity0×0.0×

Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vaxcyte, Inc.'s net income?: Vaxcyte, Inc. (PCVX) reported net income of -$320.62M in Q1 2026.
How has Vaxcyte, Inc.'s net income changed year-over-year?: Vaxcyte, Inc.'s net income decreased by 127.8% year-over-year, from -$140.72M to -$320.62M.
What is the long-term trend for Vaxcyte, Inc.'s net income?: Over 4 years (2021 to 2025), Vaxcyte, Inc.'s net income has grown at a 66.4% compound annual growth rate (CAGR), from -$100.08M to -$766.63M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.